James R. Empfield serves as Executive at Xenon Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, James R. Empfield has executed 15 insider transactions totaling $3.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 12, 2022 involved exercising options for 45,000 shares valued at $213.8K.
James R. Empfield currently holds 75,000 shares of Xenon Pharmaceuticals Inc. (XENE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James R. Empfield has been a net seller of XENE stock. They have purchased $24.8K and sold $3.8M worth of shares.
James R. Empfield's most recent insider trade was on Aug 12, 2022, when they sold 45,000 shares at $4.75 per share.
Get notified when new Form 4 filings are submitted
| 7,257 |
| $38.02 |
| Discretionary |
| Aug 12, 2022 | XENE | $1.4M | Sale | 35,868 | $38.08 | Discretionary |
| Aug 12, 2022 | XENE | $846.1K | Sale | 21,875 | $38.68 | Discretionary |
| Aug 12, 2022 | XENE | $62.0K | Option Exercise | 20,000 | $3.10 | Discretionary |
| Mar 7, 2022 | XENE | $948.2K | Sale | 31,048 | $30.54 | Discretionary |
| Mar 7, 2022 | XENE | $55.3K | Sale | 1,805 | $30.62 | Discretionary |
| Mar 7, 2022 | XENE | $270.6K | Payment | 8,952 | $30.23 | Discretionary |
| Mar 7, 2022 | XENE | $270.4K | Option Exercise | 40,000 | $6.76 | Discretionary |
| Mar 7, 2022 | XENE | $21.0K | Payment | 695 | $30.23 | Discretionary |
| Mar 7, 2022 | XENE | $21.0K | Option Exercise | 2,500 | $8.40 | Discretionary |
| Mar 4, 2022 | XENE | $563.9K | Sale | 18,315 | $30.79 | Discretionary |
| Mar 4, 2022 | XENE | $210.0K | Payment | 6,685 | $31.42 | Discretionary |
| Mar 4, 2022 | XENE | $210.0K | Option Exercise | 25,000 | $8.40 | Discretionary |
| Aug 15, 2017 | XENE | $24.8K | Purchase | 10,000 | $2.48 | Discretionary |